Download video

TROP2: A Promising Breast Cancer Drug Target

244 views

Susan G. Komen®

1 year ago

TROP2: A Promising Breast Cancer Drug Target

TROP2: A Promising Breast Cancer Drug Target

The Role of the TROP2 Biomarker in Cancer
4:15
The Role of the TROP2 Biomarker in Cancer
by Debbie's Dream Foundation: Curing Stomach Cancer
TROP2: A Promising Breast Cancer Drug Target
3:48
TROP2: A Promising Breast Cancer Drug Target
by Susan G. Komen®
Breast Cancer Overview: Part 2
58:25
Breast Cancer Overview: Part 2
by Rad Onc Talks
The OncoAlert Weekly Round Up October 3 to 9, 2025. TROPION-Breast02 , IMforte
4:44
The OncoAlert Weekly Round Up October 3 to 9, 2025. TROPION-Breast02 , IMforte
by OncoAlert 360
Defining the Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Breast Cancer
15:40
Defining the Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Breast Cancer
by Research To Practice
Ongoing lung cancer trials and the potential of Trop2 biomarker at BTOG 2025
0:54
Ongoing lung cancer trials and the potential of Trop2 biomarker at BTOG 2025
by VJOncology
Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Breast Cancer — Issue 1
20:18
Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Breast Cancer — Issue 1
by Research To Practice
Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
24:48
Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
by Research To Practice
Enhertu? What’s Next for HER2-Low Breast Cancer?
2:26
Enhertu? What’s Next for HER2-Low Breast Cancer?
by CARES: Cancer Rehab Ed \& Support
Part 2 A very rare metaplastic breast cancer #metaplastic #breast #cancer
1:57
Part 2 A very rare metaplastic breast cancer #metaplastic #breast #cancer
by Metaplastic Breast Cancer Global Alliance
Do I Need Chemotherapy for Breast Cancer? Is it Safe to Skip Chemo? A Must Watch
6:26
Do I Need Chemotherapy for Breast Cancer? Is it Safe to Skip Chemo? A Must Watch
by Yerbba – Breast Cancer
ACROSS-TROP2: identifying predictive biomarkers of SG in HR+\/HER2- breast cancer
0:44
ACROSS-TROP2: identifying predictive biomarkers of SG in HR+\/HER2- breast cancer
by VJOncology
TGFβi NKs with naxitamab and gemcitabine for GD2+ breast cancer
2:45
TGFβi NKs with naxitamab and gemcitabine for GD2+ breast cancer
by VJOncology
Breast Cancer Breakthroughs: TROPION-Breast02 Trial
5:11
Breast Cancer Breakthroughs: TROPION-Breast02 Trial
by Susan G. Komen®
2025 Breast Cancer Treatment: I-SPY2 Trial’s Lobular Chemotherapy Breakthrough
5:30
2025 Breast Cancer Treatment: I-SPY2 Trial’s Lobular Chemotherapy Breakthrough
by OncologyTube
Defining the Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
17:45
Defining the Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
by Research To Practice
Anthracycline benefit in early HR+\/HER2- breast cancer
0:47
Anthracycline benefit in early HR+\/HER2- breast cancer
by VJOncology
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
1:10
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
by VJOncology
Correlation between Trop2 and pCR in patients with HER2-positive early breast cancer
1:17
Correlation between Trop2 and pCR in patients with HER2-positive early breast cancer
by VJOncology
Navigating the clinical impact of TROP2-targeting in NSCLC
56:43
Navigating the clinical impact of TROP2-targeting in NSCLC
by Touch Medical Media
Datopotamab Deruxtecan in NSCLC: A Closer Look at TROP2-Targeted Therapy
1:54
Datopotamab Deruxtecan in NSCLC: A Closer Look at TROP2-Targeted Therapy
by Oncology Brothers Clips